ACI
FMI

AMP Capital Investors’s Foundation Medicine, Inc. FMI Stock Holding History

AMP Capital Investors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,550
Closed -$223K – 1247
2017
Q3 		$223K Sell
5,550
-470
-8% -$18.1K ﹤0.01% 1098
2017
Q2 		$244K Buy
+6,020
New +$220K ﹤0.01% 1082

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AMP Capital Investors's FMI Position: Q4 2017 in Review

AMP Capital Investors sold out of Foundation Medicine, Inc. (FMI) in Q4 2017, closing a stake of 5,550 shares — an estimated $223K sold.

AMP Capital Investors first reported a position in FMI in Q2 2017 and held it in 2 quarters. The position peaked at $244K in Q2 2017. 127 funds tracked by Wall St. Rank hold FMI as of Q4 2017.

  • AMP Capital Investors reported no remaining Foundation Medicine, Inc. position as of Q4 2017 after selling out during the quarter.
  • AMP Capital Investors sold 5,550 Foundation Medicine, Inc. shares in Q4 2017, an estimated $223K.
  • AMP Capital Investors first reported a position in Foundation Medicine, Inc. in Q2 2017 and held it in 2 quarters.
  • AMP Capital Investors's Foundation Medicine, Inc. position peaked at $244K in Q2 2017.
  • 127 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2017.

Based on AMP Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.